×


 x 

Shopping cart
21%OFFJohn L. Lamattina - Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image? - 9781118487471 - V9781118487471
Stock image for illustration purposes only - book cover, edition or condition may vary.

Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?

€ 36.99
€ 29.11
You save € 7.88!
FREE Delivery in Ireland
Description for Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image? Paperback. An expert's view on solving the challenges confronting today's pharmaceutical industry Author John LaMattina, a thirty-year veteran of the pharmaceutical industry and former president of Pfizer's Global R&D Division, is internationally recognized as an expert on the pharmaceutical industry. Num Pages: 136 pages, charts. BIC Classification: KNDP; MMG. Category: (P) Professional & Vocational. Dimension: 232 x 156 x 9. Weight in Grams: 192.

An expert's view on solving the challenges confronting today's pharmaceutical industry

Author John LaMattina, a thirty-year veteran of the pharmaceutical industry and former president of Pfizer's Global R&D Division, is internationally recognized as an expert on the pharmaceutical industry. His first book, Drug Truths: Dispelling the Myths About Pharma R&D, was critically acclaimed for clearing up misconceptions about the pharmaceutical industry and providing an honest account of the contributions of pharmaceutical research and development to human health and well-being.

As he toured the country discussing Drug Truths, Dr. LaMattina regularly came across people who were filled with anger, accusing the ... Read more

Starting with "4 Secrets that Drug Companies Don't Want You to Know," Devalued and Distrusted provides a fact-based account of how the pharmaceutical industry works and the challenges it faces. It addresses such critical issues as:

  • Why pharmaceutical R&D productivity has declined
  • Where pharmaceutical companies need to invest their resources
  • What can be done to solve core health challenges, including cancer, diabetes, and neurodegenerative diseases
  • How the pharmaceutical industry can regain public trust and resuscitate its image

Our understanding of human health and disease grows daily; however, converting science into medicine is increasingly challenging. Reading Devalued and Distrusted, you'll not only gain a greater appreciation of those challenges, but also the role that the pharmaceutical industry currently plays and can play in solving those challenges.


Get to know the author: Read an interview with John LaMattina or watch a video on ChemistryViews!

Interview: John LaMattina: 30 Years in Pharma

Video: Can the Pharmaceutical Industry Restory its Broken Image?

Show Less

Product Details

Format
Paperback
Publication date
2013
Publisher
John Wiley & Sons Inc United States
Number of pages
136
Condition
New
Number of Pages
136
Place of Publication
New York, United States
ISBN
9781118487471
SKU
V9781118487471
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50

About John L. Lamattina
JOHN L. LaMATTINA, PHD, retired as president of Pfizer's Global Research and Development in 2007, where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous honors and awards, including an Honorary Doctor of Science from the University of New Hampshire. Currently a Senior Partner with PureTech Ventures, he ... Read more

Reviews for Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?
"Oz should invite LaMattina back on his show.  Since LaMattina treats all concerns respectfully, Oz needn’t worry about feeling devalued or distrusted."  (Barron's, 5 May 2014) “This is an honest book by an insider who believes in the basic good that the industry does.”  (The Quarterly Review of Biology, 1 September 2013) “Summing Up:  Recommended.  General ... Read more

Goodreads reviews for Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?


Subscribe to our newsletter

News on special offers, signed editions & more!